Anticancer
drug names under consideration by the United States
afusertib,
inolisib, nesvacumab, nindetanib
A
name published in the USP Dictionary of USAN and International Nonproprietary
Names, and on the United States Adopted Names Web site, shall be the effective
equivalent of an intellectual property right on the part of the relevant
entities.
:
afursertib: treatment of hematological
cancers
inolisib: treatment of cancer
nesvacumab: treatment of cancer
nintedanib: antineoplastic
Aucun commentaire:
Enregistrer un commentaire